Minerva Neurosciences Inc (NERV) - Pendapatan lan volume dodolan
The Minerva Neurosciences (NERV) business model is subject to binary risks due to the concentration of resources on a single drug. The company's aggregate performance on the GURU.Markets chart shows a sideways trend, where the 0.00 level serves as a critical mark. The complexity of brain research and strict regulatory oversight create high barriers, yet the establishment of a closed medical circuit ties clinics to unique schizophrenia therapy protocols.
Rincian analitis perusahaan Minerva Neurosciences, Inc. (NERV)
- kuotasi lan prakiraan analis:
- indikator kapitalisasi pasar:
- rincian nilai buku perusahaan:
- statistik kawajiban utang lan likuiditas:
Utang marang Modal Minerva Neurosciences|NERV - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Minerva Neurosciences Inc|NERV - Utang perusahaan|Rasio utang marang aset resik Minerva Neurosciences, Inc.|NERV - Utang jangka dawa perusahaan|Utang jangka cendhak Minerva Neurosciences|Koefisien jangkoan perantara minervaneurosciences.com
- indikator bathi lan kelipatan valuasi:
NERV - Bathi resik|Bathi mangsa ngarep Minerva Neurosciences|NERV - Pangali P/E|Kapitalisasi marang proyeksi bathi minervaneurosciences.com|NERV - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Minerva Neurosciences, Inc.|NERV - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajrone 12 wulan pungkasan Minerva Neurosciences|NERV - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan minervaneurosciences.com|NERV - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Minerva Neurosciences
- indikator volume dodolan lan pendapatan:
Analisis komprehensif perusahaan:Minerva - NERV
Investors determine business resilience by analyzing the actual cash flow from core operations. This indicator captures daily revenue from product sales, measuring the issuer's actual liquidity and capitalization rates. For Minerva Neurosciences (NERV), this flow depends directly on the commercial success of roluperidone following FDA approval. An assessment of investment risks becomes possible by studying the dynamics of the company's operating sales revenue.
Analisis perusahaan pesaing
Pendapatan perusahaan BIIB|Pendapatan lan volume dodolan NBIX|Pendapatan lan volume dodolan regencellbioscience.com (RGC)|Axsome Therapeutics, Inc. - Dodolan perusahaan|Pendapatan dodolan perusahaan ACAD|XENE - Pendapatan perusahaan|VKTX (Viking Therapeutics Corp) - Volume dodolan perusahaan|SUPN: Pendapatan lan volume dodolan|Total pendapatan perusahaan catalystpharma.com (CPRX)|Dodolan perusahaan DNLI|Pendapatan lan volume dodolan Harmony Biosciences Inc|Pendapatan perusahaan Biohaven Pharmaceutical (BHVN)|AMLX (Amylyx Corp) - Pendapatan dodolan perusahaan|Pendapatan perusahaan Trevi Therapeutics TRVI|praxismedicines.com (PRAX) - Total pendapatan perusahaan|AVXL - Pendapatan perusahaan|Pendapatan reged perusahaan CeriBell Inc CBLL|PRTA: Pendapatan lan volume dodolan|Dodolan perusahaan Alector|ANNX (Annexon, Inc.) - Pendapatan lan volume dodolan|Omeros Corp. (OMER) - Pendapatan reged perusahaan|Pendapatan lan volume dodolan NGNE|ACIU - Total pendapatan perusahaan|Pendapatan perusahaan Voyager Pharma VYGR|NMRA: Volume dodolan perusahaan|Scilex Holding Company - Pendapatan lan volume dodolan|tevogen.com (TVGN) - Dodolan perusahaan|ACOG: Pendapatan lan volume dodolan|Total pendapatan perusahaan cogrx.com (CGTX)|Pendapatan perusahaan Inhibikase|Cassava Pharma (SAVA) - Pendapatan reged perusahaan|Pendapatan perusahaan Assertio Holdings, Inc. (ASRT)|coyatherapeutics.com - Volume dodolan perusahaan|Pendapatan lan volume dodolan VTGN (Vistagen)|Ovid Therapeutics Inc (OVID) - Total pendapatan perusahaan|ABOS - Pendapatan perusahaan|Pendapatan dodolan perusahaan CRVO (CervoMed Corporation)|ATHE (alteritytherapeutics.com) - Dodolan perusahaan|CLNN (Clene) - Pendapatan perusahaan|Pendapatan perusahaan PepGen Inc|Volume dodolan perusahaan JUNS (jupiterneurosciences.com)|Pendapatan lan volume dodolan RLMD|ANVS - Total pendapatan perusahaan|Grace Therapeutics - Dodolan perusahaan|Pendapatan lan volume dodolan fireflyneuro.com AIFF|KLTO - Pendapatan perusahaan|Pendapatan dodolan perusahaan NRSN (NeuroSense Therapeutics)|Reviva Pharmaceuticals Holdings (RVPH) - Pendapatan perusahaan|Total pendapatan perusahaan MetaVia (MTVA)|Pendapatan perusahaan NeurAxis, Inc.|Dodolan perusahaan Helius Medical Technologies Inc. (HSDT)|Pendapatan lan volume dodolan PASG|Pendapatan reged perusahaan bionomics.com.au|Pendapatan perusahaan Athira ATHA|ADXN: Volume dodolan perusahaan|Alzamend - Pendapatan lan volume dodolan|Total pendapatan perusahaan Cyclerion Therapeutics|protagenic.com (PTIX) - Pendapatan perusahaan|Pasithea Therapeutics Corp. - Pendapatan dodolan perusahaan|Dodolan perusahaan CRGT|Pendapatan perusahaan ATXI|Pendapatan lan volume dodolan BCLI|Pendapatan lan volume dodolan caratherapeutics.com (CARA)|Chromocell Therapeutics Corp. - Dodolan perusahaan|Pendapatan dodolan perusahaan ELYM|ITCI - Pendapatan perusahaan|LBPH (Longboard) - Volume dodolan perusahaan|MRNS: Pendapatan lan volume dodolan|Total pendapatan perusahaan nkgenbiotech.com (NKGN)|Dodolan perusahaan NRBO|Pendapatan lan volume dodolan Sage Therapeutics Inc.|Pendapatan perusahaan Neurotrope (SNPX)|TRVN (Trevena Inc) - Pendapatan dodolan perusahaan|Pendapatan perusahaan Vigil Neuroscience, Inc. VIGL|Anew Medical Inc. (WENA) - Total pendapatan perusahaan|CERE - Pendapatan perusahaan
